The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Raymond J. Bergeron

Department of Medicinal Chemistry

University of Florida

Gainesville 32610



Name/email consistency: high



  • Department of Medicinal Chemistry, University of Florida, Gainesville 32610, USA. 1998 - 2005


  1. Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance. Bergeron, R.J., Wiegand, J., McManis, J.S., Weimar, W.R., Park, J.H., Eiler-McManis, E., Bergeron, J., Brittenham, G.M. J. Med. Chem. (2005) [Pubmed]
  2. Synthesis and biological evaluation of aminopolyamines. Bergeron, R.J., Huang, G., McManis, J.S., Yao, H., Nguyen, J.N. J. Med. Chem. (2005) [Pubmed]
  3. Polyamine-vectored iron chelators: the role of charge. Bergeron, R.J., Bharti, N., Wiegand, J., McManis, J.S., Yao, H., Prokai, L. J. Med. Chem. (2005) [Pubmed]
  4. Desferrithiocin analogue based hexacoordinate iron(III) chelators. Bergeron, R.J., Huang, G., Weimar, W.R., Smith, R.E., Wiegand, J., McManis, J.S. J. Med. Chem. (2003) [Pubmed]
  5. Methoxylation of desazadesferrithiocin analogues: enhanced iron clearing efficiency. Bergeron, R.J., Wiegand, J., McManis, J.S., Bussenius, J., Smith, R.E., Weimar, W.R. J. Med. Chem. (2003) [Pubmed]
  6. Polyamine-iron chelator conjugate. Bergeron, R.J., McManis, J.S., Franklin, A.M., Yao, H., Weimar, W.R. J. Med. Chem. (2003) [Pubmed]
  7. HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning. Bergeron, R.J., Wiegand, J., Brittenham, G.M. Blood (2002) [Pubmed]
  8. Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferatives. Bergeron, R.J., Müller, R., Huang, G., McManis, J.S., Algee, S.E., Yao, H., Weimar, W.R., Wiegand, J. J. Med. Chem. (2001) [Pubmed]
  9. Significance of asymmetric sites in choosing siderophores as deferration agents. Bergeron, R.J., Xin, M.G., Weimar, W.R., Smith, R.E., Wiegand, J. J. Med. Chem. (2001) [Pubmed]
  10. Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferatives. Bergeron, R.J., Müller, R., Bussenius, J., McManis, J.S., Merriman, R.L., Smith, R.E., Yao, H., Weimar, W.R. J. Med. Chem. (2000) [Pubmed]
  11. Metabolism and pharmacokinetics of N1,N11-diethylnorspermine in a Cebus apella primate model. Bergeron, R.J., Merriman, R.L., Olson, S.G., Wiegand, J., Bender, J., Streiff, R.R., Weimar, W.R. Cancer Res. (2000) [Pubmed]
  12. Pharmacokinetics of orally administered desferrithiocin analogs in cebus apella primates. Bergeron, R.J., Weimar, W.R., Wiegand, J. Drug Metab. Dispos. (1999) [Pubmed]
  13. The origin of the differences in (R)- and (S)-desmethyldesferrithiocin. Iron-clearing properties. Bergeron, R.J., Wiegand, J., Ratliff-Thompson, K., Weimar, W.R. Ann. N. Y. Acad. Sci. (1998) [Pubmed]
WikiGenes - Universities